Primary Venous Thromboembolism Prophylaxis in Ambulatory Cancer Patients

20139 citationsReview

Authors

Garrett B. Aikens · University of Montana

Michael P. Rivey · University of Montana

Abstract

Use of antithrombotic agents has reduced the rate of primary VTE, with minimal increases in bleeding risk in specific ambulatory cancer populations. Further investigation is needed to guide and narrow recommendations for primary VTE prophylaxis in ambulatory cancer patients.

Topics & Keywords

Venous Thromboembolism Diagnosis and Management Central Venous Catheters and Hemodialysis Atrial Fibrillation Management and Outcomes

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: Annals of Pharmacotherapy

Volume 47, Issue 2, pp. 198-209

DOI: 10.1345/aph.1r335

Field-Weighted Citation Impact: 1.17